Edward B. Skibo

1.8k total citations
66 papers, 1.5k citations indexed

About

Edward B. Skibo is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Edward B. Skibo has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Organic Chemistry, 39 papers in Molecular Biology and 18 papers in Toxicology. Recurrent topics in Edward B. Skibo's work include Cancer therapeutics and mechanisms (19 papers), Bioactive Compounds and Antitumor Agents (18 papers) and Synthesis and Biological Evaluation (14 papers). Edward B. Skibo is often cited by papers focused on Cancer therapeutics and mechanisms (19 papers), Bioactive Compounds and Antitumor Agents (18 papers) and Synthesis and Biological Evaluation (14 papers). Edward B. Skibo collaborates with scholars based in United States. Edward B. Skibo's co-authors include WILLIAM G. SCHULZ, Imadul Islam, Robert O. Dempcy, Romesh C. Boruah, Robert T. Dorr, Ru Zhou, Daniel V. LaBarbera, Omar M. Khdour, Chengguo Xing and Robert H. Lemus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Edward B. Skibo

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward B. Skibo United States 23 1.2k 599 358 78 65 66 1.5k
Mohammad Behforouz United States 21 815 0.7× 321 0.5× 184 0.5× 92 1.2× 57 0.9× 36 1.1k
Jean‐Yves Mérour France 26 2.0k 1.7× 775 1.3× 150 0.4× 112 1.4× 146 2.2× 98 2.3k
Raymond Houssin France 22 976 0.8× 782 1.3× 146 0.4× 208 2.7× 72 1.1× 103 1.5k
Masaji Kasai Japan 18 621 0.5× 569 0.9× 263 0.7× 243 3.1× 63 1.0× 64 1.1k
Brigitte Baldeyrou France 23 749 0.6× 710 1.2× 165 0.5× 136 1.7× 46 0.7× 42 1.3k
Jeffrey A. McKie United States 16 868 0.8× 323 0.5× 71 0.2× 75 1.0× 92 1.4× 18 1.0k
William A. Remers United States 22 1.0k 0.9× 774 1.3× 322 0.9× 161 2.1× 56 0.9× 102 1.5k
Jean‐François Peyrat France 28 1.6k 1.4× 559 0.9× 113 0.3× 167 2.1× 148 2.3× 70 2.1k
Wayne K. Anderson United States 20 945 0.8× 433 0.7× 68 0.2× 82 1.1× 97 1.5× 77 1.3k
Subas M. Sakya United States 19 790 0.7× 483 0.8× 69 0.2× 201 2.6× 53 0.8× 37 1.1k

Countries citing papers authored by Edward B. Skibo

Since Specialization
Citations

This map shows the geographic impact of Edward B. Skibo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward B. Skibo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward B. Skibo more than expected).

Fields of papers citing papers by Edward B. Skibo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward B. Skibo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward B. Skibo. The network helps show where Edward B. Skibo may publish in the future.

Co-authorship network of co-authors of Edward B. Skibo

This figure shows the co-authorship network connecting the top 25 collaborators of Edward B. Skibo. A scholar is included among the top collaborators of Edward B. Skibo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward B. Skibo. Edward B. Skibo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khdour, Omar M. & Edward B. Skibo. (2009). Quinone methide chemistry of prekinamycins: 13C- labeling, spectral global fitting and in vitro studies. Organic & Biomolecular Chemistry. 7(10). 2140–2140. 35 indexed citations
2.
Hargreaves, Robert H. J., Cynthia L. David, Luke Whitesell, et al.. (2008). Discovery of Quinolinediones Exhibiting a Heat Shock Response and Angiogenesis Inhibition. Journal of Medicinal Chemistry. 51(8). 2492–2501. 14 indexed citations
3.
LaBarbera, Daniel V. & Edward B. Skibo. (2004). Synthesis of imidazo[1,5,4-de]quinoxalin-9-ones, benzimidazole analogues of pyrroloiminoquinone marine natural products. Bioorganic & Medicinal Chemistry. 13(2). 387–395. 35 indexed citations
4.
Hargreaves, Robert H. J., Cynthia L. David, Luke Whitesell, & Edward B. Skibo. (2003). Design of quinolinedione-Based geldanamycin analogues. Bioorganic & Medicinal Chemistry Letters. 13(18). 3075–3078. 15 indexed citations
6.
SCHULZ, WILLIAM G., R.A. Nieman, & Edward B. Skibo. (1995). Evidence for DNA phosphate backbone alkylation and cleavage by pyrrolo[1,2-a]benzimidazoles: small molecules capable of causing base-pair-specific phosphodiester bond hydrolysis.. Proceedings of the National Academy of Sciences. 92(25). 11854–11858. 23 indexed citations
7.
SCHULZ, WILLIAM G., Imadul Islam, & Edward B. Skibo. (1995). Pyrrolo[1,2-a]benzimidazole-Based Quinones and Iminoquinones. The Role of the 3-Substituent on Cytotoxicity. Journal of Medicinal Chemistry. 38(1). 109–118. 46 indexed citations
9.
Boruah, Romesh C. & Edward B. Skibo. (1994). A Comparison of the Cytotoxic and Physical Properties of Aziridinyl Quinone Derivatives Based on the Pyrrolo[1,2-a]benzimidazole and Pyrrolo[1,2-a]indole Ring Systems. Journal of Medicinal Chemistry. 37(11). 1625–1631. 39 indexed citations
10.
Skibo, Edward B. & WILLIAM G. SCHULZ. (1993). Pyrrolo[1,2-a]benzimidazole-based aziridinyl quinones. A new class of DNA cleaving agent exhibiting G and A base specificity. Journal of Medicinal Chemistry. 36(21). 3050–3055. 52 indexed citations
13.
Islam, Imadul, Edward B. Skibo, Robert T. Dorr, & David S. Alberts. (1991). Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents. Journal of Medicinal Chemistry. 34(10). 2954–2961. 61 indexed citations
14.
Dempcy, Robert O. & Edward B. Skibo. (1991). Rational design of quinazoline-based irreversible inhibitors of human erythrocyte purine nucleoside phosphorylase. Biochemistry. 30(34). 8480–8487. 75 indexed citations
15.
Islam, Imadul & Edward B. Skibo. (1990). Synthesis and physical studies of azamitosene and iminoazamitosene reductive alkylating agents. Iminoquinone hydrolytic stability, syn/anti isomerization, and electrochemistry. The Journal of Organic Chemistry. 55(10). 3195–3205. 29 indexed citations
16.
Skibo, Edward B., James H. Gilchrist, & Changhee Lee. (1987). Electronic probes of the mechanism of substrate oxidation by buttermilk xanthine oxidase: role of the active-site nucleophile in oxidation. Biochemistry. 26(11). 3032–3037. 21 indexed citations
17.
Skibo, Edward B., et al.. (1987). Active-site-directed reductive alkylation of xanthine oxidase by imidazo[4,5-g]quinazoline-4,9-diones functionalized with a leaving group. Biochemistry. 26(23). 7355–7362. 10 indexed citations
19.
Skibo, Edward B. & Thomas C. Bruice. (1983). High- and low-potential flavin mimics (based on the pyrimidino[5,4-g]pteridine and imidazo[4,5-g]pteridine system). 1. General chemistry. Journal of the American Chemical Society. 105(10). 3304–3315. 7 indexed citations
20.
Meyer, Rich B. & Edward B. Skibo. (1979). Synthesis of fused [1,2,6]thiadiazine 1,1-dioxides as potential transition-state analog inhibitors of xanthine oxidase and guanase. Journal of Medicinal Chemistry. 22(8). 944–948. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026